Introduction to Glioma Inactivated

Sentence Examples

Discover more insights into Glioma Inactivated

Keywords frequently search together with Glioma Inactivated

Narrow sentence examples with built-in keyword filters

Glioma Inactivated sentence examples within contactin associated protein

contactin associated protein

Background Morvan syndrome (MoS) is a rare autoimmune syndrome associated with antibodies against two kinds of potassium channel proteins, contactin associated protein-like 2 (CASPR2) and leucine-rich glioma inactivated protein 1 (LGI1).

Morvan syndrome associated with LGI1 antibody: a case report

contactin associated protein

In this study, we screened pairs of serum and CSF samples from antipsychotic-naïve individuals with first-episode schizophrenic psychosis (FEP, n = 103), clinical high risk for psychosis (CHR, n = 47), and healthy volunteers (HV, n = 40) for eight different antibodies against various antigens that have been shown to be associated with autoimmune encephalitides: N-methyl-D-aspartate receptor (NMDAR, NR1 subunits only), glutamic acid decarboxylase (GAD65), leucine-rich glioma inactivated protein 1 (LGI1), contactin-associated protein-like 2 protein (CASPR2), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit 1, AMPAR subunit 2, γ-aminobutyric acid-B receptors (GABABR), and glycine receptors.

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers

More contactin associated protein sentences More Sentences

Glioma Inactivated sentence examples within anti leucine rich

anti leucine rich

OBJECTIVE To evaluate the cognitive and neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis.

Neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 encephalitis.

anti leucine rich

0%) and anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis group (20, 76.

Seasonal variation in autoimmune encephalitis: A multi-center retrospective study

More anti leucine rich sentences More Sentences

Glioma Inactivated sentence examples within amino 3 hydroxy

amino 3 hydroxy

Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABAAR) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2).

Thymoma and Autoimmune Encephalitis

amino 3 hydroxy

Herpes simplex DNA-PCR, antibodies against Nmethyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl4-isoxazolepropionic acid (AMPA1&2), contactin-associated protein (CASPR1), leucine-rich glioma inactivated 1 (LGI1), and gamma-amino butyric acid (GABAB) receptors were not detected in the CSF.

GAD65-Related Immune Epilepsy: Are we Looking Yet?

More amino 3 hydroxy sentences More Sentences

Learn more from Glioma Inactivated

Glioma Inactivated sentence examples within 5 methyl 4

5 methyl 4

Anti-Nmethyl-D-aspartate (NMDA) receptor antibody, anti-leucinerich glioma inactivated 1 (LGI1) antibody, anti-α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), and antibody-related encephalitis mainly affect the limbic system.

Recurrent anti-AMPA receptor encephalitis associated with thymus cancer

More 5 methyl 4 sentences More Sentences

Glioma Inactivated sentence examples within Rich Glioma Inactivated

Rich Glioma Inactivated

A randomized controlled trial confirmed that one 1st line compound (intravenous immunoglobulins) is superior to a placebo in patients with antibodies against leucine-rich glioma inactivated protein 1.

Management of autoimmune encephalitis.

Rich Glioma Inactivated

Background Morvan syndrome (MoS) is a rare autoimmune syndrome associated with antibodies against two kinds of potassium channel proteins, contactin associated protein-like 2 (CASPR2) and leucine-rich glioma inactivated protein 1 (LGI1).

Morvan syndrome associated with LGI1 antibody: a case report

More Rich Glioma Inactivated sentences More Sentences

Glioma Inactivated sentence examples within glioma inactivated 1

glioma inactivated 1

Finally, we compared the CSF proteomic profile of five anti-AK5 patients with that of 40 controls and 10 cases with other more common non-paraneoplastic LE (five with antibodies against leucine-rich glioma inactivated 1 and five against contactin-associated protein-like 2), as well as 10 cases with paraneoplastic neurological syndromes (five with antibodies against Yo and five against Ma2).

Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis.

glioma inactivated 1

OBJECTIVE To evaluate the cognitive and neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis.

Neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 encephalitis.

More glioma inactivated 1 sentences More Sentences

Glioma Inactivated sentence examples within glioma inactivated protein

glioma inactivated protein

A randomized controlled trial confirmed that one 1st line compound (intravenous immunoglobulins) is superior to a placebo in patients with antibodies against leucine-rich glioma inactivated protein 1.

Management of autoimmune encephalitis.

glioma inactivated protein

Background Morvan syndrome (MoS) is a rare autoimmune syndrome associated with antibodies against two kinds of potassium channel proteins, contactin associated protein-like 2 (CASPR2) and leucine-rich glioma inactivated protein 1 (LGI1).

Morvan syndrome associated with LGI1 antibody: a case report

More glioma inactivated protein sentences More Sentences

Glioma Inactivated sentence examples within glioma inactivated 3

glioma inactivated 3

Background: In-vitro studies showed that Leucine-rich glioma inactivated 3 (LGI3) is a keratinocyte-derived cytokine that stimulates melanin synthesis and is increased after ultra violet B (UVB) irradiation.

Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients*

glioma inactivated 3

BACKGROUND In-vitro studies showed that Leucine-rich glioma inactivated 3 (LGI3) is a keratinocyte-derived cytokine that stimulates melanin synthesis and is increased after ultra violet B (UVB) irradiation.

Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.

More glioma inactivated 3 sentences More Sentences

More Glioma Inactivated sentence examples
10.3390/brainsci9100267

Among patients with AE, eight patients had definite AE (Immunolobulin G for N-methyl-D-aspartate receptor n = 4, Leucine-rich, glioma inactivated 1 n = 2, Ma 2 n = 1, and Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid n = 1).

Therapeutic Plasma Exchange in Multiple Sclerosis and Autoimmune Encephalitis: A Comparative Study of Indication, Efficacy, and Safety

More Glioma Inactivated sentence examples
10.3389/fneur.2019.00539

7%) for anti-LGI1 (leucine-rich, glioma inactivated 1); 3 patients (3.

Clinical Characteristics and Short-Term Prognosis of Autoimmune Encephalitis: A Single-Center Cohort Study in Changsha, China

Learn more from Glioma Inactivated

Keywords related to Glioma

Glioma Inactivated
Encyclopedia

What is/are Glioma Inactivated?

Glioma Inactivated - Among patients with AE, eight patients had definite AE (Immunolobulin G for N-methyl-D-aspartate receptor n = 4, Leucine-rich, glioma inactivated 1 n = 2, Ma 2 n = 1, and Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid n = 1). [1] 7%) for anti-LGI1 (leucine-rich, glioma inactivated 1); 3 patients (3. [2]

contactin associated protein

Background Morvan syndrome (MoS) is a rare autoimmune syndrome associated with antibodies against two kinds of potassium channel proteins, contactin associated protein-like 2 (CASPR2) and leucine-rich glioma inactivated protein 1 (LGI1). [1] In this study, we screened pairs of serum and CSF samples from antipsychotic-naïve individuals with first-episode schizophrenic psychosis (FEP, n = 103), clinical high risk for psychosis (CHR, n = 47), and healthy volunteers (HV, n = 40) for eight different antibodies against various antigens that have been shown to be associated with autoimmune encephalitides: N-methyl-D-aspartate receptor (NMDAR, NR1 subunits only), glutamic acid decarboxylase (GAD65), leucine-rich glioma inactivated protein 1 (LGI1), contactin-associated protein-like 2 protein (CASPR2), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit 1, AMPAR subunit 2, γ-aminobutyric acid-B receptors (GABABR), and glycine receptors. [2] Finally, we compared the CSF proteomic profile of five anti-AK5 patients with that of 40 controls and 10 cases with other more common non-paraneoplastic LE (five with antibodies against leucine-rich glioma inactivated 1 and five against contactin-associated protein-like 2), as well as 10 cases with paraneoplastic neurological syndromes (five with antibodies against Yo and five against Ma2). [3] Serum antibodies against intracellular and cell surface antigens (antiHu, Ri, Yo, PNMA2 [Ma2/Ta], CV2, amphiphysin, recoverin, SOX1, titin, Zic4, Delta/Notch-like epidermal growth factor-related receptor [DNER/Tr], glutamic acid decarboxylase 65 [GAD65], N-methyl-D-aspartate receptor [NMDAR], leucine-rich glioma inactivated 1 [LGI1], contactin-associated protein-like 2 [CASPR2], gammaaminobutyric acid b receptor [GABAbR], AMPA 1 and 2 receptors, dipeptidyl-peptidase-like protein 6 [DPPX], aquaporin 4, and myelin oligodendrocyte glycoprotein [MOG]) were absent, as were cerebrospinal fluid antibodies against cell surface antigens. [4] Autoantibodies including contactin-associated protein 2 (CASPR2), leucine-rich glioma inactivated protein 1 (LGl1) or IgLON5 antibody were detected in three patients, and another patient had Sjogren's syndrome. [5] Contactin-associated protein-like 2 antibodies and leucine-rich glioma inactivated protein 1 antibodies were detected as positive. [6] These antigens are usually leucine-rich, glioma inactivated 1 (LGI1), and contactin associated protein-like 2 (CASPR2). [7] Patients with acute neurological disorders and anti-N-methyl-D-aspartate receptor (NMDAR), γ-aminobutyric acid B receptor (GABABR), leucine-rich glioma inactivated 1, or contactin-associated protein-like 2 (CASPR2) antibodies were included. [8] Objective To explore the clinical characteristics of autoimmune disease with dual seropositive antibodies of leucine-rich glioma inactivated 1(LGI1)and contactin-associated protein 2(Caspr2). [9] Investigation of a broad panel of antibodies revealed serum leucine-rich glioma inactivated protein 1 and contactin-associated protein 2 antibodies. [10]

anti leucine rich

OBJECTIVE To evaluate the cognitive and neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis. [1] 0%) and anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis group (20, 76. [2] Case presentation Here we present a case of anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis who presented with only typical facio-brachial dystonic seizures at presentation. [3] Introduction Anti-leucine-rich glioma inactivated-1 (LGI-1) is one of few antibodies implicated in limbic encephalitis, a syndrome that can result in permanent neurological symptoms if left untreated. [4] 4%) patients had AES, of whom 3 had anti-leucine-rich glioma inactivated 1, 3 had anti-contactin-associated protein-like 2, 1 had anti-N-methyl-d-aspartate receptor, and 13 had antiglutamic acid decarboxylase 65 (enzyme-linked immunosorbent assay concentrations >10 000 IU/mL). [5] Rationale: Anti leucine-rich glioma inactivated 1 (LGI1) limbic encephalitis (LE) is rare autoimmune encephalitis, characterized by acute or subacute cognitive impairment, faciobrachial dystonic seizures, mental disorders, and refractory hyponatremia. [6] Additionally, the detection rates of different antibodies among epilepsy patients were as follows: anti-NMDAR, 1%; anti-leucine-rich glioma inactivated 1 (LGI1), 1%; anti-contactin-associated protein-like 2 (CASPR2), 2%. [7] 167 nmol/L) and titin (MG titin-30) antibody, but negative for anti-leucine-rich glioma inactivated-1 and anti-contactin-associated protein-2 antibodies. [8]

amino 3 hydroxy

Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABAAR) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). [1] Herpes simplex DNA-PCR, antibodies against Nmethyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl4-isoxazolepropionic acid (AMPA1&2), contactin-associated protein (CASPR1), leucine-rich glioma inactivated 1 (LGI1), and gamma-amino butyric acid (GABAB) receptors were not detected in the CSF. [2]

5 methyl 4

Anti-Nmethyl-D-aspartate (NMDA) receptor antibody, anti-leucinerich glioma inactivated 1 (LGI1) antibody, anti-α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), and antibody-related encephalitis mainly affect the limbic system. [1]

Rich Glioma Inactivated

A randomized controlled trial confirmed that one 1st line compound (intravenous immunoglobulins) is superior to a placebo in patients with antibodies against leucine-rich glioma inactivated protein 1. [1] Background Morvan syndrome (MoS) is a rare autoimmune syndrome associated with antibodies against two kinds of potassium channel proteins, contactin associated protein-like 2 (CASPR2) and leucine-rich glioma inactivated protein 1 (LGI1). [2] In this study, we screened pairs of serum and CSF samples from antipsychotic-naïve individuals with first-episode schizophrenic psychosis (FEP, n = 103), clinical high risk for psychosis (CHR, n = 47), and healthy volunteers (HV, n = 40) for eight different antibodies against various antigens that have been shown to be associated with autoimmune encephalitides: N-methyl-D-aspartate receptor (NMDAR, NR1 subunits only), glutamic acid decarboxylase (GAD65), leucine-rich glioma inactivated protein 1 (LGI1), contactin-associated protein-like 2 protein (CASPR2), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit 1, AMPAR subunit 2, γ-aminobutyric acid-B receptors (GABABR), and glycine receptors. [3] Finally, we compared the CSF proteomic profile of five anti-AK5 patients with that of 40 controls and 10 cases with other more common non-paraneoplastic LE (five with antibodies against leucine-rich glioma inactivated 1 and five against contactin-associated protein-like 2), as well as 10 cases with paraneoplastic neurological syndromes (five with antibodies against Yo and five against Ma2). [4] OBJECTIVE To evaluate the cognitive and neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis. [5] 0%) and anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis group (20, 76. [6] In addition, the development of synapses also seems to be affected by the interaction of the LGI (leucine-rich glioma inactivated) protein family with the ADAM (a disintegrin and metalloprotease) ones. [7] Serum antibodies against intracellular and cell surface antigens (antiHu, Ri, Yo, PNMA2 [Ma2/Ta], CV2, amphiphysin, recoverin, SOX1, titin, Zic4, Delta/Notch-like epidermal growth factor-related receptor [DNER/Tr], glutamic acid decarboxylase 65 [GAD65], N-methyl-D-aspartate receptor [NMDAR], leucine-rich glioma inactivated 1 [LGI1], contactin-associated protein-like 2 [CASPR2], gammaaminobutyric acid b receptor [GABAbR], AMPA 1 and 2 receptors, dipeptidyl-peptidase-like protein 6 [DPPX], aquaporin 4, and myelin oligodendrocyte glycoprotein [MOG]) were absent, as were cerebrospinal fluid antibodies against cell surface antigens. [8] Leucine-Rich Glioma Inactivated protein 1 (LGI1) is a secreted neuronal protein highly expressed in the central nervous system and high amount are found in the hippocampus. [9] Case presentation Here we present a case of anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis who presented with only typical facio-brachial dystonic seizures at presentation. [10] Autoantibodies including contactin-associated protein 2 (CASPR2), leucine-rich glioma inactivated protein 1 (LGl1) or IgLON5 antibody were detected in three patients, and another patient had Sjogren's syndrome. [11] At the genetic level, many mutations may take place in proteins like axon guidance proteins, leucine‐rich glioma inactivated 1 protein, microtubular protein, pore‐forming, chromatin remodeling, and chemokine proteins which may lead toward temporal lobe epilepsy. [12] Gleichzeitig unterscheiden sich AK-assoziierte neuroimmunologische Erkrankungen in ihrem Pathomechanismus: Während bei der AQP4-Neuromyelitis-optica-SpektrumErkrankung („neuromyelitis optica spectrum disorders“, NMOSD) aufgrund der zugrunde liegenden komplementfixierenden Immunglobulin(Ig)G1/IgG3AK Komplementinhibition effektiv ist, wird diese bei nichtkomplementfixierenden IgG4-AK-assoziierten Erkrankungen (MUSK[muskelspezifische Rezeptor-Tyrosinkinase]-Myasthenia-gravis, LGI1[„leucine-rich glioma inactivated protein 1“]-limbische Enzephalitis etc. [13] Introduction Anti-leucine-rich glioma inactivated-1 (LGI-1) is one of few antibodies implicated in limbic encephalitis, a syndrome that can result in permanent neurological symptoms if left untreated. [14] 4%) patients had AES, of whom 3 had anti-leucine-rich glioma inactivated 1, 3 had anti-contactin-associated protein-like 2, 1 had anti-N-methyl-d-aspartate receptor, and 13 had antiglutamic acid decarboxylase 65 (enzyme-linked immunosorbent assay concentrations >10 000 IU/mL). [15] Rationale: Anti leucine-rich glioma inactivated 1 (LGI1) limbic encephalitis (LE) is rare autoimmune encephalitis, characterized by acute or subacute cognitive impairment, faciobrachial dystonic seizures, mental disorders, and refractory hyponatremia. [16] Herpes simplex DNA-PCR, antibodies against Nmethyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl4-isoxazolepropionic acid (AMPA1&2), contactin-associated protein (CASPR1), leucine-rich glioma inactivated 1 (LGI1), and gamma-amino butyric acid (GABAB) receptors were not detected in the CSF. [17] Additionally, the detection rates of different antibodies among epilepsy patients were as follows: anti-NMDAR, 1%; anti-leucine-rich glioma inactivated 1 (LGI1), 1%; anti-contactin-associated protein-like 2 (CASPR2), 2%. [18] 167 nmol/L) and titin (MG titin-30) antibody, but negative for anti-leucine-rich glioma inactivated-1 and anti-contactin-associated protein-2 antibodies. [19] 8%), leucine-rich glioma inactivated-1 protein (LGI1) (1. [20] Introduction Leucine-rich glioma inactivated-1 antibody encephalitis has been associated with bradycardia as a neurocardiac prodrome. [21] Objective We evaluated pain in leucine-rich glioma inactivated1(LGI1) and contactin-associated protein2(CASPR2)-antibody positive(Ab+) patients, to evaluate clinical associations and pathophysiology of treatable pain syndromes. [22] Background: In-vitro studies showed that Leucine-rich glioma inactivated 3 (LGI3) is a keratinocyte-derived cytokine that stimulates melanin synthesis and is increased after ultra violet B (UVB) irradiation. [23] BACKGROUND In-vitro studies showed that Leucine-rich glioma inactivated 3 (LGI3) is a keratinocyte-derived cytokine that stimulates melanin synthesis and is increased after ultra violet B (UVB) irradiation. [24] Contactin-associated protein-like 2 antibodies and leucine-rich glioma inactivated protein 1 antibodies were detected as positive. [25] Among 12 cases of children with AE, there were 11 cases of children with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and 1 case of child with anti-leucine-rich glioma inactivated protein 1 (LGI1) antibody-associated encephalitis. [26] Additionally, 4 potential ubiquitination substrates for RNF5 were predicted, including sorting nexin 10, proprotein convertase subtilisin/kexin type 1, leucine rich glioma inactivated 1 and solute carrier family 39 member 12. [27] Patients with acute neurological disorders and anti-N-methyl-D-aspartate receptor (NMDAR), γ-aminobutyric acid B receptor (GABABR), leucine-rich glioma inactivated 1, or contactin-associated protein-like 2 (CASPR2) antibodies were included. [28] Constitutional mutations in Leucine‐rich glioma inactivated 1 (LGI1) predispose to an autosomal dominant epilepsy syndrome in humans and germline inactivation of LGI1 in mice leads to early onset seizures. [29] Objective To explore the clinical characteristics of autoimmune disease with dual seropositive antibodies of leucine-rich glioma inactivated 1(LGI1)and contactin-associated protein 2(Caspr2). [30] Results Nine patients suffered from anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and other 7 patients had limbic encephalitis (LE), which including 2 cases of anti-leucine-rich glioma inactivated 1(LGI1) encephalitis, 3 cases of anti-γ-aminobutyric acid-B receptor(GABABR) encephalitis, 1 case of anti-Hu encephalitis and 1 case of anti-Yo encephalitis. [31] Leucine-rich glioma inactivated-1 (LGI-1) antibody-mediated encephalitis is a subtype of autoimmune encephalopathy associated with antibody against neuronal plasma membrane proteins ADAM23 binding protein LGI-1. [32] Immunological analysis for leucine‐rich glioma inactivated 1 (LGI1) autoantibodies was negative, but antibodies against DCC (deleted in colorectal carcinoma) known as netrin‐1 receptor were found. [33] BackgroundAnti leucine-rich glioma inactivated 1 (LGI1) encephalitis is a rare autoimmune encephalitis (AE), characterized by acute or subacute cognitive impairment, faciobrachial dystonic seizures, psychiatric disturbances and hyponatremia. [34] Purpose: Antibodies against leucine-rich glioma inactivated 1 (LGI1) are associated with limbic encephalitis and faciobrachial dystonic seizures (FBDS). [35] Serological testing later was positive for antileucine-rich glioma inactivated 1 antibody. [36] It is now generally accepted that Bfaciobrachial dystonic seizures^ (FBDS)—thought to be pathognomonic for leucine-rich glioma inactivated-1 (LGI-1)-antibody encephalitis—lack EEG correlates [2] and in the recent past their epileptic nature was also questioned [3]. [37] Investigation of a broad panel of antibodies revealed serum leucine-rich glioma inactivated protein 1 and contactin-associated protein 2 antibodies. [38]

glioma inactivated 1

Finally, we compared the CSF proteomic profile of five anti-AK5 patients with that of 40 controls and 10 cases with other more common non-paraneoplastic LE (five with antibodies against leucine-rich glioma inactivated 1 and five against contactin-associated protein-like 2), as well as 10 cases with paraneoplastic neurological syndromes (five with antibodies against Yo and five against Ma2). [1] OBJECTIVE To evaluate the cognitive and neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis. [2] 0%) and anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis group (20, 76. [3] Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABAAR) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). [4] Serum antibodies against intracellular and cell surface antigens (antiHu, Ri, Yo, PNMA2 [Ma2/Ta], CV2, amphiphysin, recoverin, SOX1, titin, Zic4, Delta/Notch-like epidermal growth factor-related receptor [DNER/Tr], glutamic acid decarboxylase 65 [GAD65], N-methyl-D-aspartate receptor [NMDAR], leucine-rich glioma inactivated 1 [LGI1], contactin-associated protein-like 2 [CASPR2], gammaaminobutyric acid b receptor [GABAbR], AMPA 1 and 2 receptors, dipeptidyl-peptidase-like protein 6 [DPPX], aquaporin 4, and myelin oligodendrocyte glycoprotein [MOG]) were absent, as were cerebrospinal fluid antibodies against cell surface antigens. [5] Case presentation Here we present a case of anti-leucine-rich glioma inactivated 1 (LGI1) encephalitis who presented with only typical facio-brachial dystonic seizures at presentation. [6] At the genetic level, many mutations may take place in proteins like axon guidance proteins, leucine‐rich glioma inactivated 1 protein, microtubular protein, pore‐forming, chromatin remodeling, and chemokine proteins which may lead toward temporal lobe epilepsy. [7] 4%) patients had AES, of whom 3 had anti-leucine-rich glioma inactivated 1, 3 had anti-contactin-associated protein-like 2, 1 had anti-N-methyl-d-aspartate receptor, and 13 had antiglutamic acid decarboxylase 65 (enzyme-linked immunosorbent assay concentrations >10 000 IU/mL). [8] Rationale: Anti leucine-rich glioma inactivated 1 (LGI1) limbic encephalitis (LE) is rare autoimmune encephalitis, characterized by acute or subacute cognitive impairment, faciobrachial dystonic seizures, mental disorders, and refractory hyponatremia. [9] Herpes simplex DNA-PCR, antibodies against Nmethyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl4-isoxazolepropionic acid (AMPA1&2), contactin-associated protein (CASPR1), leucine-rich glioma inactivated 1 (LGI1), and gamma-amino butyric acid (GABAB) receptors were not detected in the CSF. [10] Anti-Nmethyl-D-aspartate (NMDA) receptor antibody, anti-leucinerich glioma inactivated 1 (LGI1) antibody, anti-α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), and antibody-related encephalitis mainly affect the limbic system. [11] Additionally, the detection rates of different antibodies among epilepsy patients were as follows: anti-NMDAR, 1%; anti-leucine-rich glioma inactivated 1 (LGI1), 1%; anti-contactin-associated protein-like 2 (CASPR2), 2%. [12] Among patients with AE, eight patients had definite AE (Immunolobulin G for N-methyl-D-aspartate receptor n = 4, Leucine-rich, glioma inactivated 1 n = 2, Ma 2 n = 1, and Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid n = 1). [13] 7%) for anti-LGI1 (leucine-rich, glioma inactivated 1); 3 patients (3. [14] These antigens are usually leucine-rich, glioma inactivated 1 (LGI1), and contactin associated protein-like 2 (CASPR2). [15] Additionally, 4 potential ubiquitination substrates for RNF5 were predicted, including sorting nexin 10, proprotein convertase subtilisin/kexin type 1, leucine rich glioma inactivated 1 and solute carrier family 39 member 12. [16] Patients with acute neurological disorders and anti-N-methyl-D-aspartate receptor (NMDAR), γ-aminobutyric acid B receptor (GABABR), leucine-rich glioma inactivated 1, or contactin-associated protein-like 2 (CASPR2) antibodies were included. [17] Constitutional mutations in Leucine‐rich glioma inactivated 1 (LGI1) predispose to an autosomal dominant epilepsy syndrome in humans and germline inactivation of LGI1 in mice leads to early onset seizures. [18] Objective To explore the clinical characteristics of autoimmune disease with dual seropositive antibodies of leucine-rich glioma inactivated 1(LGI1)and contactin-associated protein 2(Caspr2). [19] Results Nine patients suffered from anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and other 7 patients had limbic encephalitis (LE), which including 2 cases of anti-leucine-rich glioma inactivated 1(LGI1) encephalitis, 3 cases of anti-γ-aminobutyric acid-B receptor(GABABR) encephalitis, 1 case of anti-Hu encephalitis and 1 case of anti-Yo encephalitis. [20] Immunological analysis for leucine‐rich glioma inactivated 1 (LGI1) autoantibodies was negative, but antibodies against DCC (deleted in colorectal carcinoma) known as netrin‐1 receptor were found. [21] BackgroundAnti leucine-rich glioma inactivated 1 (LGI1) encephalitis is a rare autoimmune encephalitis (AE), characterized by acute or subacute cognitive impairment, faciobrachial dystonic seizures, psychiatric disturbances and hyponatremia. [22] Purpose: Antibodies against leucine-rich glioma inactivated 1 (LGI1) are associated with limbic encephalitis and faciobrachial dystonic seizures (FBDS). [23] Serological testing later was positive for antileucine-rich glioma inactivated 1 antibody. [24]

glioma inactivated protein

A randomized controlled trial confirmed that one 1st line compound (intravenous immunoglobulins) is superior to a placebo in patients with antibodies against leucine-rich glioma inactivated protein 1. [1] Background Morvan syndrome (MoS) is a rare autoimmune syndrome associated with antibodies against two kinds of potassium channel proteins, contactin associated protein-like 2 (CASPR2) and leucine-rich glioma inactivated protein 1 (LGI1). [2] In this study, we screened pairs of serum and CSF samples from antipsychotic-naïve individuals with first-episode schizophrenic psychosis (FEP, n = 103), clinical high risk for psychosis (CHR, n = 47), and healthy volunteers (HV, n = 40) for eight different antibodies against various antigens that have been shown to be associated with autoimmune encephalitides: N-methyl-D-aspartate receptor (NMDAR, NR1 subunits only), glutamic acid decarboxylase (GAD65), leucine-rich glioma inactivated protein 1 (LGI1), contactin-associated protein-like 2 protein (CASPR2), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit 1, AMPAR subunit 2, γ-aminobutyric acid-B receptors (GABABR), and glycine receptors. [3] Leucine-Rich Glioma Inactivated protein 1 (LGI1) is a secreted neuronal protein highly expressed in the central nervous system and high amount are found in the hippocampus. [4] Autoantibodies including contactin-associated protein 2 (CASPR2), leucine-rich glioma inactivated protein 1 (LGl1) or IgLON5 antibody were detected in three patients, and another patient had Sjogren's syndrome. [5] Gleichzeitig unterscheiden sich AK-assoziierte neuroimmunologische Erkrankungen in ihrem Pathomechanismus: Während bei der AQP4-Neuromyelitis-optica-SpektrumErkrankung („neuromyelitis optica spectrum disorders“, NMOSD) aufgrund der zugrunde liegenden komplementfixierenden Immunglobulin(Ig)G1/IgG3AK Komplementinhibition effektiv ist, wird diese bei nichtkomplementfixierenden IgG4-AK-assoziierten Erkrankungen (MUSK[muskelspezifische Rezeptor-Tyrosinkinase]-Myasthenia-gravis, LGI1[„leucine-rich glioma inactivated protein 1“]-limbische Enzephalitis etc. [6] Contactin-associated protein-like 2 antibodies and leucine-rich glioma inactivated protein 1 antibodies were detected as positive. [7] Among 12 cases of children with AE, there were 11 cases of children with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and 1 case of child with anti-leucine-rich glioma inactivated protein 1 (LGI1) antibody-associated encephalitis. [8] Investigation of a broad panel of antibodies revealed serum leucine-rich glioma inactivated protein 1 and contactin-associated protein 2 antibodies. [9]

glioma inactivated 3

Background: In-vitro studies showed that Leucine-rich glioma inactivated 3 (LGI3) is a keratinocyte-derived cytokine that stimulates melanin synthesis and is increased after ultra violet B (UVB) irradiation. [1] BACKGROUND In-vitro studies showed that Leucine-rich glioma inactivated 3 (LGI3) is a keratinocyte-derived cytokine that stimulates melanin synthesis and is increased after ultra violet B (UVB) irradiation. [2]